LAMEA Human Growth Hormone Market By Application (Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy) By Country, Industry Analysis and Forecast, 2019 - 2025
The Latin America, Middle East and Africa Human Growth Hormone Market would witness market growth of 9.4% CAGR during the forecast period (2019-2025).
Excessive release of growth hormones induces pituitary tumor, consisting of the anterior pituitary somatotroph cells. Such somatotroph cells are healthy and grow slowly, releasing excess growth hormones. This causes headaches, blurred vision due to pressure on the optic nerves, other hormonal deficiencies, and thickening of the bones of the jaw, toes, and fingers, which ultimately results in jaw heaviness and an increase in the size of the digits called acromegaly.
Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is a well-known clinical condition in adults. It is characterized by defects in the metabolism of the substrate, body composition, physical and psychosocial functioning, all of which increase after GH replacement.
Turner Syndrome is an uncommon chromosomal disorder that harms females and is defined by a partial or complete loss of one of the X chromosomes. Symptoms of Turner syndrome are a wide neck and low or indistinct hairline, vulnerability to high blood pressure, minor eye problems, eyelid drops, and underactive thyroid gland. The age of diagnosis dropped significantly with a greater understanding of Turner Syndrome in the medical community, which, in turn, is fueling the market. As it is associated with several complications related to heart disease, autoimmune disorders, hearing loss, mental health problems, infertility and pregnancy complications, the demand for growth hormone treatment is rising.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
Excessive release of growth hormones induces pituitary tumor, consisting of the anterior pituitary somatotroph cells. Such somatotroph cells are healthy and grow slowly, releasing excess growth hormones. This causes headaches, blurred vision due to pressure on the optic nerves, other hormonal deficiencies, and thickening of the bones of the jaw, toes, and fingers, which ultimately results in jaw heaviness and an increase in the size of the digits called acromegaly.
Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is a well-known clinical condition in adults. It is characterized by defects in the metabolism of the substrate, body composition, physical and psychosocial functioning, all of which increase after GH replacement.
Turner Syndrome is an uncommon chromosomal disorder that harms females and is defined by a partial or complete loss of one of the X chromosomes. Symptoms of Turner syndrome are a wide neck and low or indistinct hairline, vulnerability to high blood pressure, minor eye problems, eyelid drops, and underactive thyroid gland. The age of diagnosis dropped significantly with a greater understanding of Turner Syndrome in the medical community, which, in turn, is fueling the market. As it is associated with several complications related to heart disease, autoimmune disorders, hearing loss, mental health problems, infertility and pregnancy complications, the demand for growth hormone treatment is rising.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
- Small for Gestational Age
- Prader-Willi Syndrome
- Idiopathic Short Stature
- Turner Syndrome
- Growth Hormone Deficiency and
- Pediatric Growth Hormone Deficiency
- Adult Growth Hormone Deficiency
- Other Applications
- Retail Pharmacy
- Hospital Pharmacy
- Specialty Pharmacy
- Online Pharmacy
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Merck Group
- Teva Pharmaceuticals Industries Ltd.
- Ipsen Pharma Biotech SAS
- Novartis AG (Sandoz International GmbH)
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
- Ferring Holdings SA
- Novo Nordisk A/S
- Eli Lilly and Company
- Anhui Anke Biotechnology Group Co., Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Human Growth Hormone Market, by Application
1.4.2 LAMEA Growth Hormone Deficiency Application Market, by Type
1.4.3 LAMEA Human Growth Hormone Market, by Distribution Channel
1.4.4 LAMEA Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 LAMEA Small for Gestational Age Market by Country
3.2 LAMEA Prader-Willi Syndrome Market by Country
3.3 LAMEA Idiopathic Short Stature Market by Country
3.4 LAMEA Turner Syndrome Market by Country
3.5 LAMEA Growth Hormone Deficiency Market by Country
3.5.1 LAMEA Growth Hormone Deficiency Application Market by Type
3.5.1.1 LAMEA Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 LAMEA Adult Growth Hormone Deficiency Market by Country
3.6 LAMEA Other Applications Market by Country
CHAPTER 4. LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 LAMEA Retail Pharmacy Market by Country
4.2 LAMEA Hospital Pharmacy Market by Country
4.3 LAMEA Specialty Pharmacy Market by Country
4.4 LAMEA Online Pharmacy Market by Country
CHAPTER 5. LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 Brazil Human Growth Hormone Market
5.1.1 Brazil Human Growth Hormone Market by Application
5.1.1.1 Brazil Growth Hormone Deficiency Application Market by Type
5.1.2 Brazil Human Growth Hormone Market by Distribution Channel
5.2 Argentina Human Growth Hormone Market
5.2.1 Argentina Human Growth Hormone Market by Application
5.2.1.1 Argentina Growth Hormone Deficiency Application Market by Type
5.2.2 Argentina Human Growth Hormone Market by Distribution Channel
5.3 UAE Human Growth Hormone Market
5.3.1 UAE Human Growth Hormone Market by Application
5.3.1.1 UAE Growth Hormone Deficiency Application Market by Type
5.3.2 UAE Human Growth Hormone Market by Distribution Channel
5.4 Saudi Arabia Human Growth Hormone Market
5.4.1 Saudi Arabia Human Growth Hormone Market by Application
5.4.1.1 Saudi Arabia Growth Hormone Deficiency Application Market by Type
5.4.2 Saudi Arabia Human Growth Hormone Market by Distribution Channel
5.5 South Africa Human Growth Hormone Market
5.5.1 South Africa Human Growth Hormone Market by Application
5.5.1.1 South Africa Growth Hormone Deficiency Application Market by Type
5.5.2 South Africa Human Growth Hormone Market by Distribution Channel
5.6 Nigeria Human Growth Hormone Market
5.6.1 Nigeria Human Growth Hormone Market by Application
5.6.1.1 Nigeria Growth Hormone Deficiency Application Market by Type
5.6.2 Nigeria Human Growth Hormone Market by Distribution Channel
5.7 Rest of LAMEA Human Growth Hormone Market
5.7.1 Rest of LAMEA Human Growth Hormone Market by Application
5.7.1.1 Rest of LAMEA Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of LAMEA Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Human Growth Hormone Market, by Application
1.4.2 LAMEA Growth Hormone Deficiency Application Market, by Type
1.4.3 LAMEA Human Growth Hormone Market, by Distribution Channel
1.4.4 LAMEA Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 LAMEA Small for Gestational Age Market by Country
3.2 LAMEA Prader-Willi Syndrome Market by Country
3.3 LAMEA Idiopathic Short Stature Market by Country
3.4 LAMEA Turner Syndrome Market by Country
3.5 LAMEA Growth Hormone Deficiency Market by Country
3.5.1 LAMEA Growth Hormone Deficiency Application Market by Type
3.5.1.1 LAMEA Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 LAMEA Adult Growth Hormone Deficiency Market by Country
3.6 LAMEA Other Applications Market by Country
CHAPTER 4. LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 LAMEA Retail Pharmacy Market by Country
4.2 LAMEA Hospital Pharmacy Market by Country
4.3 LAMEA Specialty Pharmacy Market by Country
4.4 LAMEA Online Pharmacy Market by Country
CHAPTER 5. LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 Brazil Human Growth Hormone Market
5.1.1 Brazil Human Growth Hormone Market by Application
5.1.1.1 Brazil Growth Hormone Deficiency Application Market by Type
5.1.2 Brazil Human Growth Hormone Market by Distribution Channel
5.2 Argentina Human Growth Hormone Market
5.2.1 Argentina Human Growth Hormone Market by Application
5.2.1.1 Argentina Growth Hormone Deficiency Application Market by Type
5.2.2 Argentina Human Growth Hormone Market by Distribution Channel
5.3 UAE Human Growth Hormone Market
5.3.1 UAE Human Growth Hormone Market by Application
5.3.1.1 UAE Growth Hormone Deficiency Application Market by Type
5.3.2 UAE Human Growth Hormone Market by Distribution Channel
5.4 Saudi Arabia Human Growth Hormone Market
5.4.1 Saudi Arabia Human Growth Hormone Market by Application
5.4.1.1 Saudi Arabia Growth Hormone Deficiency Application Market by Type
5.4.2 Saudi Arabia Human Growth Hormone Market by Distribution Channel
5.5 South Africa Human Growth Hormone Market
5.5.1 South Africa Human Growth Hormone Market by Application
5.5.1.1 South Africa Growth Hormone Deficiency Application Market by Type
5.5.2 South Africa Human Growth Hormone Market by Distribution Channel
5.6 Nigeria Human Growth Hormone Market
5.6.1 Nigeria Human Growth Hormone Market by Application
5.6.1.1 Nigeria Growth Hormone Deficiency Application Market by Type
5.6.2 Nigeria Human Growth Hormone Market by Distribution Channel
5.7 Rest of LAMEA Human Growth Hormone Market
5.7.1 Rest of LAMEA Human Growth Hormone Market by Application
5.7.1.1 Rest of LAMEA Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of LAMEA Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 LAMEA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 LAMEA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 LAMEA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 LAMEA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 LAMEA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 LAMEA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 LAMEA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 LAMEA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 LAMEA RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 LAMEA RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 LAMEA SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 LAMEA SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 LAMEA ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 LAMEA ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 BRAZIL HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 BRAZIL HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 BRAZIL HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 BRAZIL HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 ARGENTINA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 ARGENTINA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 ARGENTINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 ARGENTINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 ARGENTINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 ARGENTINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 UAE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 UAE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 UAE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 UAE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 UAE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 UAE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 UAE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 UAE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SAUDI ARABIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SAUDI ARABIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 68 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 69 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 70 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 71 SOUTH AFRICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SOUTH AFRICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 74 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 75 NIGERIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 76 NIGERIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 77 NIGERIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 NIGERIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 NIGERIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 NIGERIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 NIGERIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 NIGERIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 REST OF LAMEA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 84 REST OF LAMEA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 85 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 REST OF LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 90 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 91 KEY INFORMATION – MERCK GROUP
TABLE 92 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 93 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 94 KEY INFORMATION – NOVARTIS AG
TABLE 95 KEY INFORMATION – PFIZER, INC.
TABLE 96 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 97 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 98 KEY INFORMATION – NOVO NORDISK A/S
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
TABLE 1 LAMEA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 LAMEA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 LAMEA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 LAMEA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 LAMEA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 LAMEA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 LAMEA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 LAMEA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 LAMEA RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 LAMEA RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 LAMEA SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 LAMEA SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 LAMEA ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 LAMEA ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 LAMEA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 BRAZIL HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 BRAZIL HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 BRAZIL HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 BRAZIL HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 ARGENTINA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 ARGENTINA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 ARGENTINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 ARGENTINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 ARGENTINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 ARGENTINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 UAE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 UAE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 UAE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 UAE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 UAE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 UAE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 UAE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 UAE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SAUDI ARABIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SAUDI ARABIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 SAUDI ARABIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 68 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 69 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 70 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 71 SOUTH AFRICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SOUTH AFRICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 74 SOUTH AFRICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 75 NIGERIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 76 NIGERIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 77 NIGERIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 NIGERIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 NIGERIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 NIGERIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 NIGERIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 NIGERIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 REST OF LAMEA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 84 REST OF LAMEA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 85 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 REST OF LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF LAMEA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 90 REST OF LAMEA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 91 KEY INFORMATION – MERCK GROUP
TABLE 92 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 93 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 94 KEY INFORMATION – NOVARTIS AG
TABLE 95 KEY INFORMATION – PFIZER, INC.
TABLE 96 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 97 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 98 KEY INFORMATION – NOVO NORDISK A/S
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
